Grail, a deep-pocketed startup, shows ‘impressive,’ if early, results for cancer blood test M Herper, Stat News, May 31, 2019

Main|Search|PHGKB




Last Posted: May 31, 2019

---

• Grail, a deep-pocketed startup, shows ‘impressive,’ if early, results for cancer blood test
  M Herper, Stat News, May 31, 2019
• Promises and Pitfalls of Using Liquid Biopsy for Precision Medicine.
  Rossi Giovanna et al. Cancer research 2019 May
• Next generation sequencing data for use in risk assessment.
  Merrick B Alex et al. Current opinion in toxicology 2019 Dec 1818-26
• Making the invisible visible: New method opens unexplored realms for liquid biopsies
  Michigan Medicine, Eureka Alert, May 3, 2019
• IQN path ASBL report from the first European cfDNA consensus meeting: expert opinion on the minimal requirements for clinical ctDNA testing.
  Deans Zandra C et al. Virchows Archiv : an international journal of pathology 2019 Apr
• Journal of Translational Medicine advances in Translational Genomics and Genetics Era.
  Liu Wei et al. Journal of translational medicine 2019 Apr 17(1) 134
• Continuously capturing circulating cancer cells
  RP Kulkarni, Science Translational Medicine, April 24, 2019
• Towards precision medicine: advances in 5-hydroxymethylcytosine cancer biomarker discovery in liquid biopsy.
  Zeng Chang et al. Cancer communications (London, England) 2019 Mar 39(1) 12
• Utility of cfDNA Fragmentation Patterns in Designing the Liquid Biopsy Profiling Panels to Improve Their Sensitivity.
  Ivanov Maxim et al. Frontiers in genetics 2019 10194
• Potential Utility of Liquid Biopsy as a Diagnostic and Prognostic Tool for the Assessment of Solid Tumors: Implications in the Precision Oncology.
  Mathai Roshni Ann et al. Journal of clinical medicine 2019 Mar 8(3)

more